Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. - Wikidata - wikimedia - TriplyDB

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

http://www.wikidata.org/entity/Q37717276

about

Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo Mesenchymal Stem Cells after Polytrauma: Actor and Target Lysophosphatidic Acid signaling in the nervous system.The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate.Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.Promising pharmacological directions in the world of lysophosphatidic Acid signaling.Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration.1-Oleyl-lysophosphatidic acid (LPA) promotes polarization of BV-2 and primary murine microglia towards an M1-like phenotype.Plasma metabolomics profiles in rats with acute traumatic brain injury.Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson's Disease via Lysophosphatidic Acid Receptors.2-carba cyclic phosphatidic acid suppresses inflammation via regulation of microglial polarisation in the stab-wounded mouse cerebral cortex.

P2860

Q26741062-F366C336-CDAF-40F3-83F2-508909F9308D Q26747314-FBF49439-0C83-48A7-A7B4-1A0994093012 Q35456340-9CB82738-73E6-44FC-845A-D90E3D063C56 Q35770218-55630A67-C07C-44C8-AB61-47749C1E5696 Q35851510-CF2E608E-0511-4559-B7E5-BA60BD9D5F61 Q36399256-9B352769-33BE-4A0E-8F11-C517C5BFBF79 Q36591218-421F99DC-A274-45AE-B595-DCBA7D05B552 Q36731751-AD43E072-51E7-45C2-8863-A25CB00F1392 Q36991308-3C21D512-8E1E-4B72-88EA-FF605CA676D4 Q38320338-3C789596-6F8E-4227-92E2-7D27DFEA70EE Q40462969-E1E6E77A-32BC-4848-BEB8-4D05C0C0C2C7 Q40960816-18B9C319-1897-4125-93DE-335F786E3DA9 Q41235810-C30A2BAA-6107-4F65-AAE6-EFB2F81EE194 Q47118425-40A15C57-C74D-4329-B377-E1CF86AC8ADD Q52689639-B1C4BC09-309D-4495-AABC-D65C7027C975 Q55209327-AB437B91-2844-44E4-9CC7-599BE198926A Q55438711-7C796C94-22F0-4D6F-B2E4-CF15974BCB57

P2860

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

http://www.wikidata.org/entity/Q37717276

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@en

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@nl

type

label

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@en

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@nl

prefLabel

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@en

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@nl

P1433

Q37717276-47574512-0CFD-439C-A0D0-46E5F9CC439B

P1476

Q37717276-5B13392E-F234-4724-BCE2-85A0A246371A

P2093

Q37717276-4F673C78-0082-41C9-BEF4-696C809EC1E2

Q37717276-5C55AD68-3C12-4A9A-9EEA-B022EE3CFB52

Q37717276-7DA3F083-6A55-470E-82D3-4183AB118C0B

Q37717276-B8A8FB58-6416-4256-A108-F8148829F73A

Q37717276-C4F1EF7D-45AD-4B85-8AB4-64838617610A

Q37717276-C6D96DF9-745A-4B3E-961A-4566A4A5F94A

Q37717276-CC143C82-4D26-4766-90A3-E0023E4E19E8

Q37717276-CCD5D7CE-E165-411F-A417-181A495F860A

Q37717276-E39FFDC6-BA06-48E4-BDEC-ABD387BA1F84

Q37717276-F2302104-F12C-4A9D-8C65-8852B8CFC0E5

P2860

Q37717276-00DD1F9E-8CD7-45C4-8987-C79124038FD4

Q37717276-0E454E9F-78D8-4904-8AD7-854696F1E2C4

Q37717276-0F9EB87E-62C9-43EF-9C36-544984309804

Q37717276-1508AB5A-D7BD-4DC7-B9CD-6112B68D4C5F

Q37717276-281FBD89-0F3D-498C-B4AB-FF0CD2558EFA

Q37717276-2D6E6E96-B569-42DF-8479-3FA6BA953852

Q37717276-35854AB2-3118-4690-BF41-E93185B30706

Q37717276-3BB32525-DF4A-4A57-BEC4-073266092B3F

Q37717276-41BB96DC-00F8-4005-89ED-4C7FCD63B1E2

Q37717276-4FDF7566-2EB5-47D8-B787-F2A611EF7D4C

P2888

Q37717276-A2D3FC06-E225-4454-A994-C8C15A506487

P304

Q37717276-5DEF031F-CD0D-4EBF-B929-C6577CD52CAF

P31

Q37717276-E3934B6D-9D48-4A12-9139-68A2BF59EB07

P356

Q37717276-6942F9BF-E192-426A-96F5-B4659FDBBD1E

P478

Q37717276-14DBA94D-72B9-4FFF-BC56-0C3DD505332D

P50

Q37717276-05A3DC8F-8CD8-4AD8-B56B-9DE48C7BDFFC

Q37717276-98D85A86-545A-4E92-B6DD-4C9337FFF55F

Q37717276-BD3A7517-677D-40D4-8602-658E5906210B

Q37717276-D94BD342-BE96-4EA1-AE8B-4A1B1CCB8D52

Q37717276-D971FD8A-94B0-4714-8732-338DB52D5CCD

Q37717276-F281E9E8-9FD3-4330-83E6-4EF73666BF3F

P577

Q37717276-6B34760D-F2F0-4E4B-A299-A9C5E9D1A629

P5875

Q37717276-C9A3470F-0AFD-4075-A5D0-E910D884476C

P6179

Q37717276-86E8E6E3-1B2C-4EB9-8439-434C00ABF56D

P698

Q37717276-BBCCFA93-F39F-4B22-B77D-68BCFA2660AE

P921

Q37717276-59F8153C-8A8D-402B-BEB0-B4D40A9B0F95

Q37717276-DB38A89F-C947-41BE-850A-192AB4B5A0F9

P932

Q37717276-8954F28C-F1CC-4F83-BAE4-4C5C534F5AE7

P356

1742-2094-11-37

P1433

Journal of Neuroinflammation

P1476

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.

@en

P2093

Alison Conquest

http://www.w3.org/2001/XMLSchema#string

Andrew J Morris

http://www.w3.org/2001/XMLSchema#string

Ila Karve

http://www.w3.org/2001/XMLSchema#string

Jonathan K Fleming

http://www.w3.org/2001/XMLSchema#string

Jonathan M Wojciak

http://www.w3.org/2001/XMLSchema#string

Maria Daglas

http://www.w3.org/2001/XMLSchema#string

Moses Zhang

http://www.w3.org/2001/XMLSchema#string

Robert L Medcalf

http://www.w3.org/2001/XMLSchema#string

Roger A Sabbadini

http://www.w3.org/2001/XMLSchema#string

Yona Goldshmit

http://www.w3.org/2001/XMLSchema#string

P2860

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update

Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6

The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care

The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans

Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.

Kinetic exclusion assay technology: characterization of molecular interactions.

Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.

Biological effects of lysophosphatidic acid in the nervous system.

P2888

1742-2094-11-37

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-11-37

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Leigh A. Johnston

Maria Cristina Morganti-Kossmann

Maithili Sashindranath

P577

2014-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260429797

http://www.w3.org/2001/XMLSchema#string

P6179

1041042947

http://www.w3.org/2001/XMLSchema#string

P698

24576351

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

3996049

http://www.w3.org/2001/XMLSchema#string